TI
AGN

Turner Investments’s Allergan Inc AGN Stock Holding History

Turner Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,120
Closed -$2.25M – 746
2014
Q1 		$2.25M Sell
18,120
-3,730
-17% -$454K 0.06% 313
2013
Q4 		$2.43M Buy
+21,850
New +$2.09M 0.04% 366

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Turner Investments's AGN Position: Q2 2014 in Review

Turner Investments sold out of Allergan Inc (AGN) in Q2 2014, closing a stake of 18,120 shares — an estimated $2.25M sold.

Turner Investments first reported a position in AGN in Q4 2013 and held it in 2 quarters. The position peaked at $2.43M in Q4 2013. 770 funds tracked by Wall St. Rank hold AGN as of Q2 2014.

  • Turner Investments reported no remaining Allergan Inc position as of Q2 2014 after selling out during the quarter.
  • Turner Investments sold 18,120 Allergan Inc shares in Q2 2014, an estimated $2.25M.
  • Turner Investments first reported a position in Allergan Inc in Q4 2013 and held it in 2 quarters.
  • Turner Investments's Allergan Inc position peaked at $2.43M in Q4 2013.
  • 770 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2014.

Based on Turner Investments's 13F filing for Q2 2014, filed 11 Aug 2014.